On March 3, DTA held a meeting with the FDA Dental Branch and other FDA staff in Silver Springs, Md., to discuss accelerating 510(k) approvals, reprocessing dental devices, implementing UDI and the role of dental standards. More than 30 industry leaders, including representatives from ADA and the Veterans Administration, participated. Attendees praised the meeting for being an unprecedented event in other medical device segments as well as a unique opportunity to hear comments from the FDA and the opportunity to have an open and spirited exchange.
The following day, DTA members met to discuss the implications of what was learned, how we might best work with FDA in the interest of all stakeholders, among other topics. Leadership from the ADA Standards Committees for Dental Products and for Dental Informatics participated in both days and representatives of DTA are attending their upcoming committee meetings.
Watch your e-mail for the next DTA regulatory and standards digital newsletter, which will include some specifics about the aforementioned meetings, including the FDA presentation at the ADA Standards Committees for Dental Products.
DTA works hard on your behalf to help ensure that regulations and standards are not unduly burdensome on members. With continued DTA member engagement in the regulatory, standards and legislative processes, DTA can be more effective in addressing members’ concerns. We look forward to even greater participation in the coming years.
Keep in touch to learn more about upcoming meetings to include other regulatory agencies and more FDA Branches.